Recent National Health & Medical Research Council (NHMRC) Project Grant outcomes
- 2011 grant outcomes
- 2010 grant outcomes
- 2009 grant outcomes
- 2008 grant outcomes
- 2007 grant outcomes
- 2006 grant outcomes
2011
Canfell K, Clements M, Nickson C, Brotherton J, Castle P, Schiffman M, Lord S, Shi JF
Evaluation of Primary HPV Testing for Cervical Screening in Australia
$677,522.20
Haass N, Weninger W
Real-time Imaging of cell cycle progression in melanoma
$466,299
Matthews J, Mackay J, Guss J
LMO2-containing complexes in leukemia and blood cell development
$775,914
Marsh D, Baxter R
Pyk2: a central mediator of gonadotropin action in ovarian cancer
$322,524
George J, Hebbard L
Role of adiponectin in hepatic carcinogenesis
$361,082.50
Simanainen U, Handelsman D
Intraprostatic androgen signalling as a target in prostate cancer
$359,208
Bebawy M, Grau G, Combes V
Microparticles and SelectiveTrait Dominance in Multidrug Resistant Cancers
$396,273
Rizos H
Dissecting PTEN-regulated pathways in the genesis of melanoma
$292,524
Rizos Helen, Kefford R, Long G, Zhang XD
Manipulating the B-RAF/MEK pathway in the genesis and treatment of melanoma
$543,390
Halliday G, Lyons JG
Susceptibility of the basal layer of human epidermis to UVA oxidative damage due to pheomelanin and suboptimal DNA repair
$540,048
Nicholas H, Crossley M
Identifying regulators of the DNA damage response and tumourigenesis using C. Elegans
$496,706
Reddel R, Pickett H
Telomere structural abnormalities in cells using alternative lengthening of telomeres
$504,615
Stevenson A, Solomon M, Hewett P, Lumley J, Fleshman J, Clouston A, Hague W
A La CaRT: Australasian phase III randomised trial comparing laparoscopic-assisted versus open resection for rectal cancer
$ 932,568.20
Weninger W
Dynamics and mechanisms of neutrophil migration during tissue inflammation
$511,299
Clarke C, Graham J
Progesterone regulation of epithelial expansion in the normal human breast
$538,549.60
Mackay J, Blobel G
Structural and functional analysis of a cancer-linked coregulator complex
$536,706
Jolly C
Regulation of the quality of DNA repair by timing in the cell Cycle
$452,957
Fazekas De St Groth B, Shklovskaya Elena
Strategies to enhance CD4 T cell-mediated anti-tumour immunity
$511,299
2010
O'Neill G
The cell biology of glioblastoma infiltration
$508,225
Baxter R; Moore L; Marsh D; Boyle F; McCarthy N
Protein discovery for breast cancer diagnosis
$397,125
George J; Hebbard L
The role of the adiponectin receptors in liver fibrosis
$379,125
Young J; Butow P; Soloman M; Davidson P; Martin D; Harrison J
Improving psychosocial outcomes for cancer carers: a randomised control trial
$515,600
Alexander I; McCormack M; Alexander S; Thrasher A; Ginn S
Gene therapy, stress haematopoiesis and the risk of malignancy
$595,500
King M; Viney R; Pallant J; Janda M; Grimison P
Development and valuation of cancer specific multi-attribute health states for use in economic evaluation
$679,750
Richardson D; Sury Rahmanto Y; Kuchel P
Alpha-2-Macroglobulin and the Transport and Uptake of the Hormone, Hepcidin
$514,500
Weninger W; Triccas J
Visualisation of gamma-delta T cell responses in cutaneous inflammation
$550,500
Halliday G; Lyons G; Di Girolamo N; Moloney F; Lee S
Brm and Brg-1 protect from ultraviolet radiation-induced skin and ocular damage
$535,500
Richardson D; Assinder S; Dong Q
Pharmacological Targeting via AKT, PTEN, and TGF-beta Pathway Integration using
Novel Therapeutics
$611,875
Clarke S; Robertson G; Piquette-Miller M; McLachlan, A; Baker M; Katsifis A
Improving the use of chemotherapy by targeting the inflammatory response
$550,500
Crossley M; Bell-Anderson K
Transcriptional control of adipogenesis
$535,125
Liddle C; Downes M
Steroidogenic factor-1, a novel regulator of hepatic stellate cell function
$568,500
Lord S; Houssami N
Incidence and prognosis of metastatic breast cancer: A population-based data linkage study
$95,338
Reddel R; Chang A
Role of STC1 and STC2 in breast carcinogenesis
$402,125
Reddel R
Induction of senescence in cells that use the Alternative Lengthening of Telomeres (ALT) mechanism
$457,125
2009
Grimshaw J
Medicine, Central Clinical School
Determining the role of a novel gene involved in cancer blood supply
$561,500
Vardy J; Dhillon HM; van der Ploeg H; Zalcberg JR; KS Courneya; Meyer RM; Jackson CJ
Medicine, Central Clinical School
Phase III Study of the impact of a physical activity program on disease-free survival for early colon cancer
$2,418,375
Friedlander M; King MT; Gainford MC; Oza A; Fitzgerald PE
Medicine, School of Public Health
Does Palliative Chemotherapy Improve Symptoms in Women with Recurrent Ovarian Cancer?
$502,250
Quinn M; Mileshkin LR; Khaw PYL; Creutzberg CL; Friedlander ML; Gainford MC
Medicine, School of Public Health
Chemoradiation and adjuvant chemotherapy versus radiation alone in high risk and advanced endometrial cancer
$443,125
Chapman S
Medicine, School of Public Health
The use of Web 2.0 internet sites to undermine tobacco advertising bans and to mobilise tobacco control advocates
$351,000
Clarke C; Graham D
Medicine, Western Clinical School
Progesterone signalling in normal and malignant breast relies on chromosomal positioning of progesterone receptor
$546,750
Bryan TM; Cohen SB
Medicine, Children's Medical Research Institute
Structure of human telomerase
$618,500
Richardson D; Rahmanto YS
Medicine, School of Medical Sciences
The Role of Melanoma Tumour Antigen p97 (Melanotransferrin) in Melanoma Tumourenesis
$541,250
Richardson D; Kalinowski DS; Lovejoy DB; Bernhard PV
Medicine, School of Medical Sciences
Pharmacology of Potential Anti-Tumour Agents: Iron Chelators of the BpT Class
$563,500
Henderson B
Medicine, Western Clinical School
Regulation of beta-catenin location and function
$491,500
Butow P; Tattersall MHN; Clayton JM; Young JM; Davidson PM; Epstein RN
Science, Psychology
Improving QOL at the end of life: A randomised controlled trial of a doctor/nurse/patient intervention
$660,800
2008
Bendall, L; Bradstock K
Enhancement of the effects of cytotoxic agents by mTOR inhibitors in acute lymphoblastic leukemia
$642,750
Rizos H; Kefford R
Escape from BRAF-induced human melanocyte senescence in the genesis of melanoma
$577,750
Gill G; Wetzig N; Ung O; Bilous M; Campbell I; Collins J; Hague W; Kirby A
SNAC1:A randomised trial of sentinel node based management versus axillary clearance for women with small breast cancers
$1,272,850
Wetzig N; Campbell I; Gill G; Ung O; Collins J; Bilous M; Hague W; Kirby A
SNAC2: A randomised trial of extending sentinel node based management to women with larger or multifocal breast cancers
$1,185,213
Barratt A; Tattersall M; Askie L; Crossing S; Butow P; Currow D; McGeechan K
Cancer Trials Australia-OnLine: A tool for cancer patients to find open clinical trials and consider trial participation
$505,675
Clarke S; McLachlan A
Inter-ethnic differences in tolerance of anti-cancer drugs
$332,125
Jolly C; Manis J; Alt F
Antibody mutation promotes translocation: a natural cause of cancer
$293,250
Weninger W; Mrass P
Mechanisms of T cell migration and interactions in tumours
$578,250
Liddle C; Downes M
Function of the Vitamin D Receptor in Hepatic Non-Parenchymal Cells
$488,750
O’Neil C
Mechanisms of p53 induced embryopathy after in vitro fertilisation
$464,250
Henderson B
Targeting of the APC tumour suppressor to mitochondria: Implications for APC regulation and cellular function
$443,750
Scott C; Firth S
The role of the M6P/IGF-II receptor in regulating cellular function
$265,500
Clarke C
Progesterone regulation of epithelial cell lineages in the breast
$512,438
O’Neil F; Gunning P
Understanding focal adhesion dynamics in cell migration
$258,250
Mason R; Reeve V; Halliday G
Mechanisms of photoprotection by vitamin D and analogs
$420,563
Matthews J; Guss J; Trewhella J
Transcriptional complexes in haematopoiesis and T-cell Leukemia
$535,500
Suchowerska N; Jackson M; McKenzie D
Rectal invivo radiotherapy dosimetry using a Fibre Optic Array
$416,675
Bendall L; Bradstock K
Antagonists of p38 MAPK as therapeutics for acute lymphoblastic leukemia
$501,000
2007
Armstrong B
Medicine, School of Public Health
Sun exposure, vitamin D and the outcome of prostate cancer
$468,013
Armstrong B
Medicine, School of Public Health
A polypill to prevent genome damage
$395,663
McCaffery K
Medicine, School of Public Health
A randomised controlled trial of a bowel cancer screening decision aid for adults with low education and literacy
$229,500
Baxter R
Medicine, Northern Clinical School
Proteomic screening for apoptotic markers in breast cancer
$511,000
Carter S
Medicine, Central Clinical School
How do lay people understand the risk of developing cancer? A qualitative study using grounded theory procedures.
$271,125
Gill G
Medicine, Central Clinical School
SNAC1: A randomised trial of sentinel node based management versus axillary clearance for women with small breast cancers
$235,613
Halliday G
Medicine, Central Clinical School
Effect of ultraviolet radiation on development of effector and memory T cells to melanoma
$478,500
Vardy J
Medicine, Medical Psychology Unit
Cognitive Function and Fatigue in Cancer Patients After Chemotherapy
$237,525
Butow P
Science, Psychology
Psychosocial predictors of developing breast cancer in women from high risk breast cancer families
$1,020,600
Butow P
Science, Psychology
Psychological morbidity, unmet needs and patterns of care in culturally and linguistically diverse cancer patients in Australia
$401,755
2006
Harnett P
Medicine, Western Clinical School (Westmead Millennium Institute)
Certain death in uncertain time: a qualitative study of the experience of advanced ovarian cancer
$217,500
Clarke C
Medicine, Western Clinical School (Westmead Millennium Institute)
Impact of progesterone receptor submuclear localisation on progesterone action in endocrine target cells
$450,750
Soon L
Science, Electron Microscope Unit
Mechanisms of motility and metastasis in breast cancer
$205,250
Henderson B
Medicine, Western Clinical School (Westmead Millennium Institute)
Regulation of beta-catenin localisation and its role in tumour cell migration
$266,250
Halliday G
Medicine, Central Clinical School
Role of brm in skin tumour progression from benign to malignant
$447,750
Seibel M
Medicine, Central Clinical School (ANZAC Research Institute)
Glucocorticoid effects on bone: the role of the osteoblast
$455,250